Banca Mediolanum (BMED) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
1 Nov, 2025Executive summary
Net income for H1 2025 reached €477.3M, up 6% year-over-year, driven by resilient core business, robust commercial activity, and strong net inflows.
Total assets under administration rose to €144.42B (+4% vs. year-end), with net inflows of €6.11B (+8% YoY) and managed asset inflows up 47% year-over-year.
Customer base expanded by 3% to nearly 2 million, supported by targeted promotions and growth in the Family Banker network.
Credit book surpassed €18.1B, increasing 7% YoY, with a very low NPE ratio of 0.82%.
Commercial volumes rose to €8.08B, with loans granted up 48% to €1.86B, mainly from a 75% increase in mortgages.
Financial highlights
Net commission income grew 10% YoY to €644.4M, while net interest income declined 12% to €366.8M due to lower rates and higher funding costs.
Operating margin increased 1% to €570.6M; contribution margin up 2% to €1.02B.
Banking service fees up 25% to €123M, mainly from certificate sales; gross commission income rose 11% to €1.1B.
General insurance gross premiums up 23% to €114M.
Loan loss provisions down 24% YoY due to improved risk models.
Outlook and guidance
2025 guidance: managed asset inflows €8–8.5B (raised from €7.5B), net interest income expected to decrease by ~3% YoY.
Cost-to-income ratio to remain below 40% in 2025 and 2026.
Dividend for 2025 anticipated to increase from the €0.75/share base paid in 2024, with potential for a €0.20/share special dividend from Mediobanca stake sale.
NII for 2026 expected at least equal to 2025, supported by commercial initiatives and higher-yielding BTPs.
Latest events from Banca Mediolanum
- Record net income, strong asset growth, and a 25% higher dividend highlight a standout year.BMED
Q4 20253 Feb 2026 - Net income up 24% to EUR 449.9M, assets under administration EUR 129.5B, CET1 at 23.7%.BMED
Q2 20242 Feb 2026 - Net income up 18% to €674.3M, with record assets and higher interim dividend.BMED
Q3 202415 Jan 2026 - Record net income of €1.12B, €10.44B inflows, and 42% higher dividend proposed.BMED
Q4 20248 Jan 2026 - Net income up 10% YoY, record inflows, and strong capital ratios support 2025 outlook.BMED
Q1 20258 Jan 2026 - Net income up 8% to €726M, assets at €150.4B, and interim dividend raised to €0.60/share.BMED
Q3 20258 Nov 2025